ArticleCell death & disease2025

EZH2 inhibitor SHR2554 enhances the anti-tumor efficacy of HDAC inhibitor Chidamide through STAT1 in T-cell lymphoma.

Jiajin Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.